AcuraBio has appointed international biopharma executive Guillaume Herry as CEO.   Herry brings over 15 years of international operational and strategic consulting experience across the biopharmaceutical and medical device industries. AcuraBio will immediately benefit from Herry’s experience in designing and implementing growth strategies, as it leverages the business’ deep technical experience to grow the company and expand the service offering.   Herry holds an MBA from the Australian Grad...